<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01644435</url>
  </required_header>
  <id_info>
    <org_study_id>KRPL/HPL-AS/11-12/004</org_study_id>
    <nct_id>NCT01644435</nct_id>
  </id_info>
  <brief_title>A Pilot Study to Determine Safety &amp; Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring</brief_title>
  <official_title>A Prospective, Multicentric, Open Label, Bio Interventional, Phase I, Phase II Pilot Study to Evaluate the Safety and Efficacy of Autologous Human Platelet Lysate (HPL) for Treatment of Acne Scarring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasiak Research Pvt. Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasiak Research Pvt. Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of
      Human Platelet Lysate (HPL) in subjects with Acne Scarring. The study is being conducted at 2
      centers in India. The primary endpoint is change in the Global Acne scarring classification
      scores from screening to end of the study. The secondary endpoints are Photographic
      Assessment, Physicians assessment score and Patients self assessment score.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the Global Acne scarring classification</measure>
    <time_frame>Day 0, End of study - Month 3</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Photographic Assessment</measure>
    <time_frame>Day 0, Month 1, Month 2 End of study - Month 3</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Physician's assessment scores</measure>
    <time_frame>End of Study - Month 3</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient's assessment scores</measure>
    <time_frame>End of Study - Month 3</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>ACNE SCARRING</condition>
  <arm_group>
    <arm_group_label>Study arm A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects will receive a single injection of Autologous Human Platelet Lysate for acne scarring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study arm B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects will receive two injections of Autologous Human Platelet Lysate at an interval of one month for acne scarring.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous Human Platelet Lysate</intervention_name>
    <description>Subjects will receive a single injection of Autologous Human Platelet Lysate for acne scarring</description>
    <arm_group_label>Study arm A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous Human Platelet Lysate</intervention_name>
    <description>Subjects will receive two injections of Autologous Human Platelet Lysate at an interval of one month for acne scarring</description>
    <arm_group_label>Study arm B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects (male and female), aged 18 to 40 years (both inclusive).

          -  Subject willing to refrain from any other treatment of Acne Scarring during entire
             study duration.

          -  Non-pregnant, non-lactating females who agree to use adequate and acceptable methods
             of contraception from screening and throughout the course of the study.

          -  Subjects who are willing to give informed consent and adhere to the study protocol.

        Exclusion Criteria:

          -  Subjects with active infection or active acne.

          -  Subjects receiving treatment: NSAIDs treatment within the last 7 days prior to the
             study.

          -  Subjects with history of connective tissue disease.

          -  Subjects with metabolic or hematopoietic disorders.

          -  Subjects with known bleeding disorders such as platelet dysfunction syndrome,
             thrombocytopenia, hypofibrinogenemia.

          -  Subjects who have received prior chemotherapy and radiotherapy

          -  Subjects unwilling to or unable to comply with the study protocol.

          -  Subjects taking concomitant therapy that might interfere with the study results in the
             investigator's opinion or participating in another trial in the past 30days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sharmila Patil, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dermocosmetic laser center hair and skin clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pankaj Maniar, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radiance Cosmetology Clinique</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kasiak Research Pvt Ltd</name>
      <address>
        <city>Thane</city>
        <state>Maharashtra</state>
        <zip>400610</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2012</study_first_submitted>
  <study_first_submitted_qc>July 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2012</study_first_posted>
  <last_update_submitted>October 12, 2012</last_update_submitted>
  <last_update_submitted_qc>October 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

